Results 151 to 160 of about 8,855 (217)

Evaluation of the Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Inadequately Controlled With First-Generation Somatostatin Analogs. [PDF]

open access: yesFront Endocrinol (Lausanne), 2019
Gadelha M   +10 more
europepmc   +1 more source

Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs. [PDF]

open access: yesOncologist, 2019
Kiesewetter B   +7 more
europepmc   +1 more source

A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on 68Ga-DOTATATE Uptake in Patients with Neuroendocrine Tumors. [PDF]

open access: yesJ Nucl Med, 2019
Gålne A   +7 more
europepmc   +1 more source

Corrigendum: Estrogens modulate somatostatin receptors expression and synergize with the somatostatin analog pasireotide in prostate cells

open access: yesFrontiers in Pharmacology
Valentina Rossi   +8 more
doaj   +1 more source

Somatostatin analogs

The Journal of Peptide Research, 2001
Abstract:  Somatostatin is a hypothalamic peptide hormone that inhibits the secretion of growth hormone, glucagon, insulin, gastrin and secretin, and also plays a role in neural transmission. Because of its wide range of possible clinical applications hundreds of somatostatin analogs have been synthesized and bioassayed to date.
A, Janecka, M, Zubrzycka, T, Janecki
openaire   +2 more sources

Home - About - Disclaimer - Privacy